Observational studyClinical and translational science2022

Rituximab exposure-response in triweekly R-CHOP treatment in DLBCL: A loading dose is recommended to improve clinical outcomes.

Shu Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.